Education
About Us
Working with TipRanks
Follow Us
Jason Aryeh Insider Profile
25 Followers
Jason Aryeh, Director at Ligand Pharma, holds 125.91K shares in Ligand Pharma (Ticker: LGND), holds 54.79K shares in Aralez Pharmaceuticals (Ticker: ARLZQ), holds ― shares in Immunomedics (Ticker: IMMU). Most recently, Jason Aryeh Sold ― shares of Ligand Pharma on Sep 24, 2025 for an estimated value of $1.71M.
Profitable Transactions
9 out of 26 Profitable Transactions
Average Return
-2.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason Aryeh holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jason Aryeh
Jason Aryeh's Trading History
Ligand Pharma
Sep 24, 2025
Director
Informative Sell
1.71M
$21.00M
Aralez Pharmaceuticals
May 24, 2017
―
Informative Sell
556.48K
$109.57
Immunomedics
―
―
―
―
Merrimack Pharmaceuticals
Jul 18, 2019
―
Informative Buy
1.64K
$57.52K
Anebulo Pharmaceuticals
―
Director
―
―
Orchestra BioMed Holdings
Sep 19, 2025
Director
Informative Buy
2.45K
$263.61K
Lifecore Biomedical
Jul 17, 2025
Director
Uninformative Buy
―
$300.05K
Novelion Therapeutics
May 17, 2017
―
Informative Buy
3.23K
$375.91K
Vaxart
Mar 17, 2011
Director
Informative Sell
28.76K
$47.44K
List of latest transactions for each holding click on a transaction to see Jason Aryeh's performance on stock
You May Also Like
Jason Aryeh insider profile FAQ
What is the percentage of profitable transactions made by Jason Aryeh?
The percentage of profitable transactions made by Jason Aryeh is 35%.
What is the average return per transaction made by Jason Aryeh?
The average return per transaction made by Jason Aryeh is -2.50%.
What stocks does Jason Aryeh hold?
Jason Aryeh holds: LGND, ARLZQ, IMMU, MACK, ANEB, OBIO, LFCR, NVLNF, VXRT stocks.
What was Jason Aryeh’s latest transaction?
Jason Aryeh latest transaction was an Informative Sell of $1.71M.
What was Jason Aryeh's most profitable transaction?
Jason Aryeh’s most profitable transaction was an Informative Buy of LGND stock on October 9, 2014. The return on the trade was 104.80%.
What is Jason Aryeh's role in Ligand Pharma?
Jason Aryeh's role in Ligand Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.